Drug resistance and epidemiology characteristics of multidrug-resistant tuberculosis patients in 17 provinces of China-Reference-Cited by-同舟云学术

Drug resistance and epidemiology characteristics of multidrug-resistant tuberculosis patients in 17 provinces of China

Published:2019-11-21 Issue:11 Volume:14 Page:e0225361
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Lu Zhenhui,Jiang Wenhan,Zhang Jing,Lynn Henry S.,Chen Yue,Zhang Shaoyan,Ma Zifeng,Geng Peihua,Guo Xiaoyan,Zhang Huiyong,Zhang Zhijie^ORCID

Funder

13th Five-Year National Science and Technology Major Project for Infectious Diseases

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference34 articles.

1. Assessing spatial heterogeneity of MDR-TB in a high burden country;HE Jenkins;European Respiratory Journal,2013

2. XDR-TB: entering the post-antibiotic era?;M Raviglione;International Journal of Tuberculosis & Lung Disease the Official Journal of the International Union Against Tuberculosis & Lung Disease,2006

3. Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs;U States;Annals of Pharmacotherapy,2006

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TBDLNet: A network for classifying multidrug‐resistant and drug‐sensitive tuberculosis;Engineering Reports;2023-12-05

2. Cartridge-based nucleic acid amplification test in drug-resistant Mycobacterium tuberculosis as compared to solid cultures: Is it time to look beyond cartridge-based nucleic acid amplification test?;MRIMS Journal of Health Sciences;2023

3. Associations of hyponatremia and SIADH with increased mortality, young age and infection parameters in patients with tuberculosis;PLOS ONE;2022-10-13

4. Validity of automated audiometry for hearing examination in patients with multidrug-resistant tuberculosis;F1000Research;2022-08-02

5. Treatment Outcomes and Risk Factors of Multidrug-Resistant Tuberculosis Patients in Xi’an China, a Retrospective Cohort Study;Infection and Drug Resistance;2022-08